Patients dying of bowel cancer are given fresh hope thanks to a breakthrough drug combination

Global trials carried out by US drug manufacturer Bristol Myers Squibb found that prescribing the immunotherapy drugs nivolumab and ipilimumab gave highly positive results.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news